Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1637 1647 1655 1656 1799
This examiner grants 61% of resolved cases
Ciara A. McKnight is a patent examiner in Tech Center 1700, working within Art Unit 1637. The examiner has 74 resolved cases and an allowance rate of 60.8 percent. This 60.8 percent rate reflects the proportion of applications that reach a grant. For the 74 cases handled, this data provides a basis for understanding the probability of success during the examination process. The volume of resolved cases reflects the examiner's experience within Tech Center 1700.
The median days to allowance for this examiner is 1150. This 1150-day timeline represents the duration for an application to move from filing to a grant. Applicants should consider this period when planning their patent strategy and resource allocation. The volume of 74 resolved cases suggests that this duration is a consistent aspect of the examiner's workflow in Art Unit 1637. This median provides a specific metric for evaluating the expected length of prosecution.
The data shows an interview lift of 38.8 percent. This 38.8 percent lift represents the change in the likelihood of allowance when an interview is conducted. It suggests that direct communication is a method for addressing the probability of a grant. For practitioners, utilizing an interview is an option to navigate the prosecution process and achieve a positive outcome. Practitioners can use this lift to evaluate the potential benefits of direct engagement.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18717881 | CELL CRUSHING MONITORING METHOD, AND METHOD FOR PRODUCING POLYHYDROXYALKANOATES BY USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18482052 | NANOPORE TWEEZER APPROACH FOR PROTEIN KINASE ALLOSTERIC DRUG SCREENING | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18514280 | MODIFIED CELLS FOR THE PRODUCTION OF A RECOMBINANT PRODUCT OF INTEREST | Non-Final OA | Genentech, Inc. |
| 18391959 | ENGINEERED PROTEINS AND METHODS OF USE THEREOF | Final Rejection | Pairwise Plants Services, Inc. |
| 18115354 | CELL CULTURE METHODS FOR ANTIBODY PRODUCTION | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 17774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | Non-Final OA | University Of Maryland, Baltimore |
| 18165620 | METHOD OF PRODUCING HYDROGEN PEROXIDE USING MICROORGANISM OF THE GENUS DESEMZIA | Final Rejection | Gwangju Institute of Science and Technology |
| 17605499 | ENGINEERED TRANSAMINASE AND METHODS OF MAKING AND USING | Non-Final OA | Genomatica, Inc. |
| 17777245 | COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION | Non-Final OA | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 18266274 | PULSED ELECTRIC FIELD TREATMENT OF BIOLOGICAL CELLS | Final Rejection | Bühler AG |
| 18555290 | CORN OIL YIELD ENHANCEMENT THROUGH USE OF EMULSIFIERS AND EMULSIONS BY-PRODUCTS OF FERMENTATION | Non-Final OA | POET RESEARCH, INC. |
| 18599588 | AUXOTROPHIC STRAINS OF STAPHYLOCOCCUS BACTERIUM | Non-Final OA | Azitra Inc |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy